Cookie Consent

Our website uses cookies to provide your browsing experience and relavent informations.Before continuing to use our website, you agree & accept of our Cookie Policy & Privacy

APAC: +919373948803 | US: +1(682)559-7131

Chemicals and Materials

google-translate

The Mixed Mode Chromatography Resin market is projected to grow from US$ 2.56 billion in 2023 to US$ 4.98 billion by 2031, with a CAGR of 6.10% during the forecast period.


Market Overview:

Mixed mode chromatography resins find increasing application in the biopharmaceutical and chemical industries as versatile and highly effective separation tools. Designed to harness two or more interaction mechanisms, such as hydrophobicity, ionic, and hydrogen bonding, they offer superior selectivity of complex mixtures. The ability to execute multiple modes of interaction makes mixed mode resins an ideal choice for the purification of proteins, peptides, nucleic acids, and other bio- and pharmaceutical molecules.

The global mixed mode chromatography resin market has grown steadily, due to the ever-increasing demand for advanced separation techniques in drug development, diagnostics, and biomanufacturing. Mixed mode chromatography resins provide a robust solution with applications ranging from industrial-scale processes to laboratory research, as more efficient, scalable, and cost-effective purification methods become increasingly in demand. Moreover, the growth will be driven from the increasing number of biologic and biosimilars where mixed mode resins are critical components in the processes of production as well as the final purification of drugs.

Mixed-mode chromatography resins are primarily used during the purification process of biologics with high resolution and large capacity in a single step. The porosity design of the resin accepts wide varieties of feedstock differing in their properties, thereby reducing the numbers of steps or stages. This has reduced production timelines while also decreasing operating costs, hence a key product in the global biopharmaceutical industry. It also enables the possibility of improving product yield and purity, which places mixed mode chromatography as one of the key enabling technologies for future innovations in drug manufacturing.

Market Dynamics:

Drivers

  1. Growing Biopharmaceutical Industry: The increasing demand for biologics, biosimilars, and monoclonal antibodies drives the need for advanced purification techniques, such as mixed mode chromatography. These resins are crucial in the effective separation and purification of complex biological molecules.
  2. Enhanced Purification Efficiency: Mixed mode chromatography resins offer superior selectivity and high capacity, improving the efficiency of protein and biomolecule separation. Their ability to combine multiple interactions (ionic, hydrophobic, etc.) in one step provides a competitive edge in reducing purification time and cost.

Restraints

  1. High Cost of Resin: The production and maintenance costs associated with mixed mode chromatography resins can be high, limiting their adoption, especially in small-scale applications or in regions with cost-sensitive markets.
  2. Limited Availability of Skilled Workforce: The effective application of mixed mode chromatography requires highly trained professionals. The lack of skilled technicians and researchers in certain regions could pose a challenge to market growth.

Opportunities

  1. Expansion in the Biotechnology Sector: A rapidly expanding aspect in the biotechnology sector is the gene therapy and personalized medicine areas. Separations in this area involve purification and therefore represent an opportunity to meet novel biomolecules' purification demands, such as RNA-based therapeutics and gene-editing applications.
  2. Sustainability Trends: Green and sustainable biomanufacturing is increasingly on the horizon. This trend creates an opportunity for resins that have a reduced environmental impact, such as reusable mixed mode chromatography resins.

Challenges

  1. Regulatory issues: The strict regulations governing the manufacturing of biologics and pharmaceuticals can become a stumbling block for resins manufacturers in producing pure, quality, and consistency items.
  2. Cost-effectiveness: Although mixed mode chromatography provides superior performance, its cost effectiveness, especially in a highly scaled-up operation is a drawback. The manufacturers will have to work on optimum cost-to-performance ratio improvements to gain a competitive advantage in the market.

Mixed mode chromatography resin Market

Key Players:

  • Phenomenex
  • BioRad Laboratories
  • GE Healthcare,
  • Merck KGaA
  • Porvair Sciences
  • Novasep
  • Tosoh Bioscience
  • YMC Co. Ltd.
  • Agilent Technologies
  • BioWorks Technologies
  • Sepharose
  • Avantor Sciences
  • Thermo Fisher Scientific
  • Pall Corporation

Market Segmentation:

By Resin Type

  • Polymeric Resins
  • Ceramic Resins
  • Metallic Resins
  • Composite Resins

By Application

  • Protein Purification
  • Nucleic Acid Purification
  • Peptide Purification
  • Virus Purification
  • Other Applications

By Sample Type

  • Cell Culture
  • Fermentation Broth
  • Biological Fluids
  • Environmental Samples
  • Food and Beverage Samples

By Separation Mode

  • Size Exclusion Chromatography
  • Ion Exchange Chromatography
  • Affinity Chromatography
  • Hydrophobic Interaction Chromatography
  • Reversed Phase Chromatography

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East

Covid 19 Analysis:

The COVID-19 pandemic affected the mixed mode chromatography resin market both positively and negatively. On the one hand, the biopharmaceutical sector witnessed a high demand for biotherapeutics, such as vaccines and monoclonal antibodies, and this increased the demand for efficient purification techniques like mixed mode chromatography. The research and production efforts were accelerated, and the demand for high-quality resins to support vaccine and therapeutic development increased.

On the other hand, supply chain disruptions and delays in manufacturing as well as raw material shortages arising from the pandemic have been another source of challenge to resin production. In addition, a focus shift toward therapeutics for COVID-19 has slowed research projects on other areas, at least temporarily limiting broader adoption in non-COVID applications.

Nevertheless, with the global economy moving towards recovery, the long-term growth curve of the market is still upwardly inclined with more investment in biomanufacturing and increased demand for biologics providing a robust basis for expansion of the market.

Regional Analysis:

North America: The largest share of the mixed mode chromatography resin market is in North America, particularly in the U.S. The region is supported by a strong biopharmaceutical industry, with several leading companies involved in the production of biologics, monoclonal antibodies, and vaccines. The continuous innovation in biotechnology and drug development is increasing the demand for advanced purification techniques, including mixed mode chromatography. High investments in research and development and well-developed health infrastructure are key to North America being a strong market.

Europe: Europe is another significant region for the mixed mode chromatography resin market, backed by strong pharmaceutical and biotechnology industries. With a focus on personalized medicine and biologic therapies, especially in countries such as Germany, the UK, and Switzerland, the growth of advanced chromatography methods becomes even faster. Strict regulatory conditions ensure high quality production, leading to the increased applications of mixed mode chromatography resin.

Asia-Pacific: This region is likely to grow at the fastest rate over the coming few years. There is tremendous investment in biotechnology and pharmaceuticals in the region, including augmenting healthcare needs of countries such as China, India, and Japan. In addition, the developing mode of production of biosimilars and biologics makes resins for mixed mode chromatography essential for efficient purification.

Rest of the World: Middle East, Africa, and Latin America are emerging markets. The demand for biologics is on the rise and the healthcare infrastructure is also very advanced in these regions, further driving the demand for mixed mode chromatography resins. Economic constraints and scarcity of skilled professionals might act as a drag on the market growth in these regions.

Key trends:

  1. Movement towards Personalized Medicine: The growing trend towards personalized medicine, where patients undergo different modalities of treatment, requires more advanced purification technologies. Their efficacy in dealing with more complex mixtures and different kinds of biomolecules has brought mixed mode chromatography resins into increasingly common use in production of personalized therapeutic solutions.
  2. Resin technology inventions towards improvement: These resin technologies have witnessed continuous innovation in improving their performances, especially in mixed-mode resins. There are improvements in terms of stability, binding capacity, selectivity, and reusability, so that the resins become economical and efficient for large-scale biopharmaceutical manufacturing.
  3. Automation and Intensifying Processes: A fast-growing trend automation and intense process intensification for biomanufacturing. Automated systems are furnished with mixed-mode resins to further enhance the throughput, minimize hand intervention, and increase total productivity in commercial-scale operations.
  4. Sustainability and Green Chemistry: Along with all the impressive growing concerns regarding the environment, more aspects of sustainability and green chemistry in purification solutions have become the most focused today. All efforts are well motivated from manufacturers towards the use of recyclable environmentally friendly resin that can be used for green chemistry practice in biomanufacturing.

Scope of the Report

Details

Study Period

2021–2031

Base Year Considered

2023

Forecast Period

2024–2031

CAGR Value

 6.10%

Forecast Market Size

 US$ 4.98 billion

Segments Covered

Resin Type, Application, Sample Type, Separation Mode, and Region

Regions Covered

North America (the U.S. and Canada), Europe (Germany, the UK, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and LAMEA (Latin America, Middle East, and Africa)

Companies Covered

· Phenomenex

· BioRad Laboratories

· GE Healthcare,

· Merck KGaA

· Porvair Sciences

· Novasep

· Tosoh Bioscience

· YMC Co. Ltd.

· Agilent Technologies

· BioWorks Technologies

· Sepharose

· Avantor Sciences

· Thermo Fisher Scientific

· Pall Corporation

Methodology
Dynamic Market Insights is a leading market research company that follows a comprehensive and meticulous approach in conducting research. Our research process is divided into four major stages, each playing a crucial role in delivering accurate and insightful market intelligence.

Understanding Your Business Model:
We'll begin by delving deep into your business model, ensuring we understand your industry's nuances, market position, and strategic goals.

Research Process:
Our systematic process includes problem definition, literature review, research design, data collection, analysis, interpretation, and reporting.

1. Data Collection
a) Primary Research:
- The primary research stage involves the direct interaction with industry experts, stakeholders, and target audience through interviews, surveys, and focus group discussions. This step allows us to gather firsthand information, insights, and opinions directly from the key players in the market.
- By conducting primary research, we ensure that our findings are up-to-date, accurate, and reflective of the current market sentiments. This stage also enables us to validate and complement the data obtained from secondary sources.

b) Secondary Research:
- In this initial stage, we gather a wide range of data from various secondary sources, including industry reports, market publications, government databases, and reputable online sources. This step helps us build a foundation of knowledge about the market, its trends, and key players.
- The data collected at this stage provides a comprehensive overview of the industry landscape, enabling us to identify key variables and factors that influence market dynamics.

2. Sampling Strategy:
We Define the target population and employ a sampling strategy that ensures the representation of key segments within the market.
- Sampling Technique: Choose between random, stratified, or purposive sampling.
- Sample Size: Justify the size based on statistical significance and resource constraints.

3. Data Analysis:
- Following the collection of both secondary and primary data, our team of skilled analysts employs advanced statistical and analytical tools to process and analyze the gathered information. This stage involves identifying patterns, trends, correlations, and key market drivers that influence the industry.
- Our data analysis goes beyond mere numerical interpretation; we provide a qualitative assessment that adds depth to understanding market dynamics. This stage is pivotal in transforming raw data into actionable insights for our clients.

a) Quantitative Analysis:
We will employ a structured approach, utilizing surveys and statistical tools to gather and interpret numerical data. A meticulously designed questionnaire will be distributed to a representative sample, ensuring a broad spectrum of responses. Statistical methods will be applied to identify patterns, correlations, and trends, including regression analysis and data visualization. The quantitative analysis will provide an overview of market trends, customer preferences, and key metrics.

b) Qualitative Analysis:
Our qualitative analysis will involve a nuanced exploration of non-numerical data, capturing rich insights into attitudes, opinions, and behaviors. In-depth interviews and focus group discussions will be conducted to gather qualitative data. Thematic coding and content analysis techniques will be applied to categorize and interpret qualitative information systematically. This approach aims to uncover underlying motivations, perceptions, and contextual factors that may not be apparent through quantitative methods. The qualitative analysis will add depth and context to the research findings, offering a comprehensive understanding of the market landscape.

4. Market Sizing
We Determine the total addressable market (TAM) by evaluating the potential demand for the product or service within the target market.

5. Data Procurement Techniques:
We'll employ various methods such as surveys, interviews, focus groups, and a thorough review of existing data sources to ensure a well-rounded dataset.

6. Data Modeling Techniques:
Utilizing advanced statistical methods like regression analysis and data visualization to derive valuable insights from both qualitative and quantitative data.

7. Development:
- PESTEL Analysis: Scrutinizing macro-environmental factors impacting your industry.
- SWOT Analysis: Evaluating internal strengths, weaknesses, and external opportunities and threats.
- Porter's Five Forces: Assessing industry competitiveness.

8. Validation and Calibration:
DMI Validate findings through expert consultations and calibration against multiple data sources to enhance the reliability of estimates.

9. Final Result:
- R-Value: Calculating correlation coefficients to measure relationships in quantitative data.
- T-Value: Conducting statistical tests to gauge the significance of variables.
- Comprehensive Analysis: Delivering a detailed report merging qualitative and quantitative findings with actionable insights and strategic recommendations aligned with your business goals.